Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis.

Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, Inglese M.

J Neurol Sci. 2009 Jul 15;282(1-2):28-33. doi: 10.1016/j.jns.2008.12.036. Epub 2009 Jan 31.

2.

Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter.

Law M, Saindane AM, Ge Y, Babb JS, Johnson G, Mannon LJ, Herbert J, Grossman RI.

Radiology. 2004 Jun;231(3):645-52.

PMID:
15163806
3.

Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T.

Adhya S, Johnson G, Herbert J, Jaggi H, Babb JS, Grossman RI, Inglese M.

Neuroimage. 2006 Dec;33(4):1029-35. Epub 2006 Sep 22.

4.

Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis.

Ingrisch M, Sourbron S, Herberich S, Schneider MJ, Kümpfel T, Hohlfeld R, Reiser MF, Ertl-Wagner B.

Invest Radiol. 2017 Mar;52(3):135-141. doi: 10.1097/RLI.0000000000000320.

PMID:
27548346
5.

The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis.

Griffin CM, Chard DT, Parker GJ, Barker GJ, Thompson AJ, Miller DH.

J Neurol. 2002 Feb;249(2):193-9.

PMID:
11985386
6.

White matter and deep gray matter hemodynamic changes in multiple sclerosis patients with clinically isolated syndrome.

Papadaki EZ, Mastorodemos VC, Amanakis EZ, Tsekouras KC, Papadakis AE, Tsavalas ND, Simos PG, Karantanas AH, Plaitakis A, Maris TG.

Magn Reson Med. 2012 Dec;68(6):1932-42. doi: 10.1002/mrm.24194. Epub 2012 Feb 24.

7.

Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.

Hojjat SP, Kincal M, Vitorino R, Cantrell CG, Feinstein A, Zhang L, Lee L, O'Connor P, Carroll TJ, Aviv RI.

AJNR Am J Neuroradiol. 2016 Aug;37(8):1454-61. doi: 10.3174/ajnr.A4737. Epub 2016 Mar 24.

8.

Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis.

Inglese M, Adhya S, Johnson G, Babb JS, Miles L, Jaggi H, Herbert J, Grossman RI.

J Cereb Blood Flow Metab. 2008 Jan;28(1):164-71. Epub 2007 May 2.

9.

Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.

Lund H, Krakauer M, Skimminge A, Sellebjerg F, Garde E, Siebner HR, Paulson OB, Hesse D, Hanson LG.

PLoS One. 2013;8(2):e56375. doi: 10.1371/journal.pone.0056375. Epub 2013 Feb 18.

10.

Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T.

Inglese M, Park SJ, Johnson G, Babb JS, Miles L, Jaggi H, Herbert J, Grossman RI.

Arch Neurol. 2007 Feb;64(2):196-202.

PMID:
17296835
11.

Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity.

Ge Y, Law M, Johnson G, Herbert J, Babb JS, Mannon LJ, Grossman RI.

AJNR Am J Neuroradiol. 2005 Jun-Jul;26(6):1539-47.

12.

Brain macro- and microscopic damage in patients with paediatric MS.

Absinta M, Rocca MA, Moiola L, Ghezzi A, Milani N, Veggiotti P, Comi G, Filippi M.

J Neurol Neurosurg Psychiatry. 2010 Dec;81(12):1357-62. doi: 10.1136/jnnp.2010.205682. Epub 2010 Jul 26.

PMID:
20660915
13.

Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis.

Davies GR, Altmann DR, Hadjiprocopis A, Rashid W, Chard DT, Griffin CM, Tofts PS, Barker GJ, Kapoor R, Thompson AJ, Miller DH.

J Neurol. 2005 Sep;252(9):1037-44. Epub 2005 Apr 18.

PMID:
15834645
14.

Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease.

Vrenken H, Pouwels PJ, Ropele S, Knol DL, Geurts JJ, Polman CH, Barkhof F, Castelijns JA.

Mult Scler. 2007 Jul;13(6):708-16. Epub 2007 Mar 15.

PMID:
17613597
15.

Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T.

Ingrisch M, Sourbron S, Morhard D, Ertl-Wagner B, Kümpfel T, Hohlfeld R, Reiser M, Glaser C.

Invest Radiol. 2012 Apr;47(4):252-8. doi: 10.1097/RLI.0b013e31823bfc97.

PMID:
22373532
16.

Cerebral white matter blood flow and energy metabolism in multiple sclerosis.

Steen C, D'haeseleer M, Hoogduin JM, Fierens Y, Cambron M, Mostert JP, Heersema DJ, Koch MW, De Keyser J.

Mult Scler. 2013 Sep;19(10):1282-9. doi: 10.1177/1352458513477228. Epub 2013 Feb 21.

PMID:
23428956
17.

Reduced perfusion in white matter lesions in multiple sclerosis.

Sowa P, Bjørnerud A, Nygaard GO, Damangir S, Spulber G, Celius EG, Due-Tønnessen P, Harbo HF, Beyer MK.

Eur J Radiol. 2015 Dec;84(12):2605-12. doi: 10.1016/j.ejrad.2015.09.007. Epub 2015 Sep 10.

PMID:
26391230
18.

Brain hemodynamic changes associated with chronic cerebrospinal venous insufficiency are not specific to multiple sclerosis and do not increase its severity.

Garaci FG, Marziali S, Meschini A, Fornari M, Rossi S, Melis M, Fabiano S, Stefanini M, Simonetti G, Centonze D, Floris R.

Radiology. 2012 Oct;265(1):233-9. Epub 2012 Aug 21.

PMID:
22915599
19.

Regional MRI perfusion measures predict motor/executive function in patients with clinically isolated syndrome.

Papadaki EZ, Simos PG, Mastorodemos VC, Panou T, Maris TG, Karantanas AH, Plaitakis A.

Behav Neurol. 2014;2014:252419. doi: 10.1155/2014/252419. Epub 2014 Jan 23.

20.

Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.

Ramasamy DP, Benedict RH, Cox JL, Fritz D, Abdelrahman N, Hussein S, Minagar A, Dwyer MG, Zivadinov R.

J Neurol Sci. 2009 Jul 15;282(1-2):47-54. doi: 10.1016/j.jns.2008.12.034. Epub 2009 Feb 6.

PMID:
19201003

Supplemental Content

Support Center